4SC AG (LTS:0R6U) Preferred Dividends : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is 4SC AG Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. 4SC AG's preferred dividends for the six months ended in Dec. 2023 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

4SC AG Preferred Dividends Historical Data

The historical data trend for 4SC AG's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG Preferred Dividends Chart

4SC AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

4SC AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

4SC AG Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

4SC AG (LTS:0R6U) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

4SC AG (LTS:0R6U) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (LTS:0R6U) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

VSC:Germany

Address

Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152

Website

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG (LTS:0R6U) Headlines

No Headlines